Visiongain Ltd.

Visiongain is proud to announce the release of the brand new report "Respiratory Market Insight". The respiratory market contained ten blockbuster drugs in 2006, with the top three being; Advair/Seretide, Singulair and Zyrtec.

Visiongain is proud to announce the release of the brand new report "The Antipsychotics Market". The antipsychotics market will face decreasing growth throughout the forecast period, due to the patent expiry of leading blockbuster drugs.

Visiongain is proud to announce the release of the brand new report "Generic League". In 2006, the global generics market attained strong revenues of approximately $65bn, up by 12% in comparison with $58bn in 2005.

Visiongain is proud to announce the release of the brand new report "The Antibacterial Drug Market". The antibacterial market is large in terms of disease area as well as the different drug classes used to treat these infections.

Visiongain is proud to announce the release of the brand new report "Sleep Disorders: Market Analysis". At present time there are several prescription sleeping medications available to treat insomnia.

Visiongain is proud to announce the release of the brand new report "Blood Diseases Market Analysis". In 2006 visiongain valued this market at $37406m, But do you know how the blood diseases treatments market will fare 5, 10 and 15 years from now?

Visiongain is proud to announce the release of the brand new report "Chinese Pharmaceutical Outlook". This report examines the exciting Chinese pharmaceutical market and industrial sector critically through comprehensive research and analysis.

Visiongain is proud to announce the release of the brand new report "Lipitor Market Analysis". In 2006, Pfizer’s Lipitor (atorvastatin) generated global revenues of $13.6bn, making it the best selling drug in pharmaceutical history.

Visiongain is proud to announce the release of the brand new report "The Indian Pharmaceutical Market Analysis". Visiongain predicts that market for pharmaceuticals in India has strong potential for increased growth from 2008 right through to 2023.

Visiongain is proud to announce the release of the brand new report "The Pharmaceutical W&D Industry".The major problem facing the Wholesale & Distribution industry is its low profit margin which is in the region of only 1-2%.